


The stated objective of the Fund is to achieve long-term capital growth.
| Name | % Net Assets |
|---|---|
| Novozymes | 8.5% |
| Neopost | 8.2% |
| Novo Nordisk | 7.9% |
| DnB NOR | 6.7% |
| Reed Elsevier | 6.3% |
| Vopak | 4.9% |
| CGGVeritas | 4.9% |
| Euler | 4.6% |
| Syngenta | 4.6% |
| Dassault Systemes | 4.3% |
| Key | % Net Assets |
|---|---|
| 8.5% | |
| 8.2% | |
| 7.9% | |
| 6.7% | |
| 68.7% |
| Date | 20-Aug-2025 |
|---|---|
| NAV | 3,274.14p |
| Currency | GBP |
| Change | 2.67p |
| % | 0.08% |
| YTD change | 286.55p |
| YTD % | 9.59% |
| Fund Inception | 03/08/1987 |
|---|---|
| Fund Manager | n/a |
| TER | 1.78 (31-Oct-2013) |
| Minimum Investment | |
|---|---|
| Initial | £500 |
| Additional | n/a |
| Savings | £100 |
| Charges | |
|---|---|
| Initial | 5.00% |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | 0.09 |
You are here: research